Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 11, 2022
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
Bradley Canino Maintained (ZNTL) at Strong Buy with Decreased Target to $74 on, Apr 11th, 2022
Bradley Canino of Stifel, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Decreased Target from $94 to $74 on, Apr 11th, 2022.
Bradley has made no other calls on ZNTL in the last 4 months.
There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Bradley's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Bradley
- Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $67 on, Wednesday, April 6th, 2022
- Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $97 on, Friday, December 17th, 2021
